Insider Transactions in Q1 2021 at Gritstone Bio, Inc. (GRTS)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 08
2021
|
Roman Yelensky Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,724
+21.61%
|
$0
$0.76 P/Share
|
Jan 20
2021
|
Raphael Rousseau Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$250,000
$25.07 P/Share
|
Jan 20
2021
|
Raphael Rousseau Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.76 P/Share
|
Jan 19
2021
|
Roman Yelensky Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.98%
|
$220,000
$22.1 P/Share
|
Jan 19
2021
|
Raphael Rousseau Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$340,000
$17.53 P/Share
|
Jan 19
2021
|
Raphael Rousseau Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$0
$0.76 P/Share
|
Jan 07
2021
|
Andrew R Allen PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,200
+50.0%
|
-
|
Jan 07
2021
|
Matthew Hawryluk EVP, CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
19,600
+44.75%
|
-
|
Jan 07
2021
|
Karin Jooss |
BUY
Grant, award, or other acquisition
|
Direct |
27,900
+7.39%
|
-
|
Jan 07
2021
|
Rahsaan Thompson EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+46.37%
|
-
|
Jan 07
2021
|
Roman Yelensky Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,400
+13.84%
|
-
|
Jan 07
2021
|
Raphael Rousseau Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,700
+50.0%
|
-
|
Jan 07
2021
|
Vijay Yabannavar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+46.9%
|
-
|
Jan 07
2021
|
Erin Jones EVP, CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,900
+36.07%
|
-
|